Biopharmaceutical and Pharmaceutical: What’s the Difference?

Although most individuals are familiar with the pharmaceutical and biopharmaceutical sectors, the differences may be perplexing. While both industries manufacture medicines to prevent or cure medical problems, the methods utilized to create these pharmaceuticals differ. Both the biotechnology and pharmaceutical sectors manufacture medication. On the other hand, biotechnology medicines are made from living organisms, while pharmaceutical business remedies are often chemically based. To further complicate matters, the term “biopharma” was coined. Biotech companies make use of both biotechnology and chemical sources.

The Distinctions Between the Two Fields

Because most of us are probably ignorant of the differences between the two, here is a short explanation and comparison.


Biotechnology refers to the application of biological knowledge. It attempts to replicate or alter the function of a live cell for it to work in a more predictable and controlled manner. The biotechnology business uses advances in genetics research to create medications that cure human illnesses and ailments. Several biotech firms also utilize genetic technology for other purposes, such as crop modification. Biopharmaceuticals offer many potentials in treating some of the most complex medical diseases, such as cancer and autoimmune disease. Biopharmaceuticals are used to treat the symptoms and the underlying causes of a broad range of diseases and disorders. Check your supplier for the most comprehensive and quickest service offering for the biopharmaceutical sector.


Pharmaceutical firms use plant and chemical-based components to create medications that treat or manage illnesses and protect people from infection. A limited number of big companies dominate pharmaceuticals. While many of these companies provide animal health products, livestock feed additives, vitamins, and other items, the emphasis of this profile will be entirely on their pharmaceutical products used to treat human illnesses. Depending on their size and goals, pharmaceutical companies may do extensive in-house research or seek to license potential medicines from academic institutions, other pharmaceutical companies, or biotechnology firms. Biological manufacturing facilities are completely isolated, with separate utility systems servicing just their designated production zones.

The Biotech and Pharma

academic and industrial labs are the main providers of biopharmaceuticals. Venture capital firms or pharmaceutical manufacturers often fund the commercialization phase. The Food and Drug Administration (FDA) and other international regulatory agencies evaluate the safety and effectiveness of medicines before they are launched. Biotechnology offers the same opportunities as the pharmaceutical sector. Because biotech companies are still developing their first products, they place a greater emphasis on research. Biotech companies like to increase their marketing and sales teams when a promising product is on the verge of FDA clearance. Biotech firms are often geographically clustered, often near famous research institutions. Reliable production for commercial supply is one of the competencies of cGMP biologics manufacturing services.



Traditional pharmaceutical companies produce and market chemical and plant-based medications. The overwhelming majority of businesses in this industry have vitamins, animal feed supplements, and human medicines. Biotechnology and academic sectors often conduct significant in-house research to develop new goods. These drugs are made from living creatures such as mammalian cells, bacteria, and yeast. The industry’s goal is to modify or duplicate the function of a living cell to make it more controllable and predictable. The overwhelming majority of biopharmaceutical drugs are created in corporate or university research laboratories with venture capital financing. Before these medications are released, the FDA and other regulatory authorities carefully examine them.